Motley Fool February 4, 2023
By Lee Samaha

KEY POINTS

  • The earnings decline in 2022 largely came down to highly challenging supply chain conditions.
  • The current earnings and cash flow don’t reflect the company’s long-term potential.
  • Margin expansion will be critical in 2023

The newly listed healthcare company gave its first set of earnings as a stand-alone company, and while there were some negatives, its future looks bright.

One of the big investing themes for 2023 is the potential for companies to expand margins as cost inflation eases due to higher interest rates and a slowly improving supply chain. But there are two types of companies in this environment. The first type is companies whose top lines are pressured...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Medical Devices
Exo adds FDA-cleared AI tools to handheld ultrasound system
FDA spends $1.2M on VR-enabled hub to spur development of at-home care devices
FDA launches initiative to advance home healthcare models, devices
Is Telepathy Possible? Perhaps, Due To New Technology
FDA Proposes Updated Guidance Concerning Cybersecurity of Medical Devices

Share This Article